Nosocomial aspergillosis - An overview of its causes and prevention;Hospitalismus durch aspergillus - Ein uberblick uber ursachen und moglichkeiten der pravention

Wiener Klinische Wochenschrift

Volumn 110, Issue 11, 1998, Pages 388-392

  Willinger, Birgit ^a   Aspöck, Christoph ^a  

^a Institute of Environmental Hygiene   (Austria)

Author keywords

Aspergillosis; Bone marrow transplantation; Hospitalism; Immunosuppression; Neutropenia; Prevention

Indexed keywords

AMPHOTERICIN B;

ASPERGILLOSIS; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INFECTION PREVENTION; INTRANASAL DRUG ADMINISTRATION; MORTALITY; PRACTICE GUIDELINE; REVIEW;

ASPERGILLOSIS; AUSTRIA; CROSS INFECTION; HUMANS; INCIDENCE; RISK FACTORS; SURVIVAL RATE;

EID: 0032486356     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Lortholary O, Dupont B (1997) Antifungal prophylaxis during neutropenia and immundeficiency. Clin Microbiol Rev 10: 477-504
2. LaRocco MT, Burgert SJ (1997) Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 10: 277-297
3. Beyer J, Schwartz S, Heinemann V, Siegert W (1994) Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrob Agents Chemother 38: 911-917
4. Tablan OC, Anderson LJ, Arden NH, Breiman RF, Butler JC, McNeil MM et al (1994) Guideline for prevention of nosocomial pneumonia. Part I: Issues on prevention of nosocomial pneumonia -1994. Am J Infect Control 22: 247-292
5. Fridkin SK, Jarvis WR (1996) Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9: 499-511
6. Centers for Disease Control and Prevention (1997) Guide- lines for prevention of nosocomial pneumonia. MMWR 46 (No. RR-1): 1-79
7. Wald A, Leisenring W, van Burik JA, Bowden RA (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 175: 1459-1466
8. Exner M, Engelhart S (1995) Epidemiologie und Prävention der invasiven Aspergillus-Infektion. Hyg Med 20: 567-581
9. Barnes RA, Rogers TR (1989) Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect 14: 89-94
10. Vogeser M, Haas A, Aust D, Ruckdeschel G (1997) Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 16: 1-6
11. Lentino JR, Rosenkranz MA, Michaels JA, Kurup VP, Rose HD, Rytel MW (1982) Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 116: 432-437
12. Brincker H, Christensen BE, Schmidt KG, Hornstrup MK (1991) Itraconazol-Behandlung der Lungenaspergillose von Leukämiepatienten während einer nosokomialen Epidemie nach Innenraumumbaumaßnahmen. Mycoses 34: 395-400
13. Hummel M, Thalmann U, Jautzke G, Staib F, Seibold M, Hetzer R (1992) Fungal infections following heart transplantation. Mycoses 35: 23-34
14. Arnow PM, Sadigh M, Costas C, Weil D, Chudy R (1991) Endemic and epidemic aspergillosis associated with in- hospital replication of Aspergillus organisms. J Inf Dis 164: 998-1002
15. Withington S, Chambers ST, Beard ME, Inder A, Allen JR, Ikram RB et al. (1998) Invasive aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration. J Hosp Infect 38: 11-18
16. Anderson K, Morris G, Kennedy H, Croall J, Michie J, Richardson MD, et al (1996) Aspergillosis in immuno- compromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax 51: 256- 261
17. Goodley JM, Clayton YM, Hay RJ (1994) Environmental sampling for aspergilli during building construction on a hospital site. J Hosp Infect 26: 27-35